This activity was provided by grants from Congressman Jamie Raskin and by the Substance Abuse and Mental Health Services Administration.

About the speaker

Cheryl King, Ph.D., is a Professor in the Department of Psychiatry and Director of the Youth Depression and Suicide Prevention Program at the University of Michigan. A clinical psychologist, educator and research mentor, Dr. King has served as Director of Psychology Training and Chief Psychologist in the Department of Psychiatry, and she has twice received the Teacher of the Year Award in Child and Adolescent Psychiatry. A graduate of the doctoral program in clinical psychology at Indiana University, Dr. King’s research focuses on the development of culturally tailored and evidence-based practices for youth suicide risk screening, assessment, and intervention. She has provided leadership for multiple federally funded research projects, including the Youth-Nominated Support Team Intervention for Suicidal Adolescents, Emergency Department Screen for Teens at Risk for Suicide, 24-Hour Risk for Suicide Attempts in a National Cohort of Adolescents, and Answering the Alarm: A System of Care for Black Youth at Risk for Suicide. Dr. King has provided testimony in the U.S. Senate on youth suicide prevention and served as a member of the National Advisory Mental Health Council (NIMH Council). She is a Past President of the American Association of Suicidology, the Association of Psychologists in Academic Health Centers, and the Society for Clinical Child and Adolescent Psychology.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services, or off-label uses of product(s) during this presentation.

Cheryl King, PhD, reported that she was a scientific advisor and stockholder to Oui Therapeutics and Vytyl Health Management, in the past 24 months. Through review of her disclosures and research, Sheppard Pratt found that she is the owner of a company with a commercial interest. She will not discuss content directly related to the business lines or products of the companies named in this presentation. All conflicts of interest were mitigated through review of her presentation materials.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Deepak Prabhakar, MD, Elizabeth Ryznar, MD, MSc, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PhD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Stacey Garnett, RN, MSN, Stephanie M. Robinson, MSN, RN, PMH-BC, NPD-BC, NE-BC , Heather Billings, RN, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.